Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Notes underwriting agrmnt
Adamis Pharmaceuticals Corp (ADMP) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 SC 13G INTRACOASTAL CAPITAL, LLC reports a 7.6% stake in Adamis Pharmaceuticals Corporation
02/28/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/12/2019 SC 13G 683 Capital Management, LLC reports a 6.7% stake in Adamis Pharmaceuticals Corporation
08/09/2019 SC 13G CVI Investments, Inc. reports a 5.1% stake in Adamis Pharmaceuticals Corporation
02/11/2019 SC 13G FIRST MANHATTAN CO reports a 7.2% stake in Adamis Pharmaceuticals Corp
04/24/2017 SC 13G Adamis Pharmaceuticals Corp reports a 5.6% stake in Adamis Pharmaceuticals Corporation
08/09/2016 SC 13G SABBY MANAGEMENT, LLC reports a 7.7% stake in Adamis Pharmaceuticals Corporation
08/08/2016 SC 13G CVI Investments, Inc. reports a 5.5% stake in Adamis Pharmaceuticals Corporation
06/18/2012 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
08/04/2004 SC 13G FULLER & THALER ASSET MANAGEMENT, INC. reports a 5.3% stake in Cellegy Pharmaceuticals, Inc.
02/15/2000 SC 13G JANUS CAPITAL MANAGEMENT LLC reports a 6% stake in Cellegy Pharmaceuticals, Inc.
09/04/1998 SC 13G FOUR PARTNERS reports a 16.9% stake in Cellegy Pharmaceuticals, Inc.
02/27/1998 SC 13G FRONTIER CAPITAL MANAGEMENT CO LLC /ADV reports a 7.5% stake in CELLEGY PHARMACEUTICALS INC
02/09/1998 SC 13G FMR CORP reports a 6% stake in Cellegy Pharmaceuticals Incorporated

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy